Journal article
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study
- Abstract:
-
To describe rates of confirmed and suspected neutropenic sepsis (NS) and associated hospital resource utilisation in patients with non-small cell lung cancer (NSCLC) treated with docetaxel monotherapy following relapse after ≥1 line of chemotherapy in routine UK clinical practice.A multi-centre, retrospective, observational research study was conducted in seven centres across England and Wales. Adult patients with stage III/IV NSCLC initiated on docetaxel monotherapy between 2010 and 2016 in ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
Actions
Access Document
- Files:
-
-
(tiff, 125.9KB)
-
(pdf, 257.4KB)
-
(tiff, 212.8KB)
-
- Publisher copy:
- 10.1016/j.lungcan.2017.09.014
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Roche Products Ltd
More from this funder
pH Associates
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lung Cancer Journal website
- Volume:
- 113
- Pages:
- 115-120
- Publication date:
- 2017-09-27
- Acceptance date:
- 2017-09-25
- DOI:
- EISSN:
-
1872-8332
- ISSN:
-
0169-5002
- Pubs id:
-
pubs:738042
- URN:
-
uri:cc683fc7-9b68-449f-82a9-1e92f174588e
- UUID:
-
uuid:cc683fc7-9b68-449f-82a9-1e92f174588e
- Local pid:
- pubs:738042
Item Description
- Language:
- English
- Keywords:
Terms of use
- Copyright holder:
- Talbot et al.
- Copyright date:
- 2017
- Notes:
-
Copyright © 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record